Life Science

A small molecule that at 1-25 &microM improves ER protein-folding ability, stimulates the expression of multiple chaperone proteins, and induces phosphorylation of eIF2&alpha to reduce protein synthesis exerts antidiabetic activity in both ob/ob

A small molecule that at 1-25 &microM improves ER protein-folding ability, stimulates the expression of multiple chaperone proteins, and induces phosphorylation of eIF2&alpha to reduce protein synthesis exerts antidiabetic activity in both ob/ob

A monobactam antibiotic that is effective against Gram-negative bacteria but inactive against Gram-positive bacteria.

A monobactam antibiotic that is effective against Gram-negative bacteria but inactive against Gram-positive bacteria.

A monobactam antibiotic that is effective against Gram-negative bacteria but inactive against Gram-positive bacteria.

A monobactam antibiotic that is effective against Gram-negative bacteria but inactive against Gram-positive bacteria.

A muscle relaxant that inhibits the release of calcium from skeletal muscle sarcoplasmic reticulum inhibits a component of store-operated calcium entry (SOCE) that is coupled to the skeletal muscle ryanodine receptor, with 20 &microM azumolene

A muscle relaxant that inhibits the release of calcium from skeletal muscle sarcoplasmic reticulum inhibits a component of store-operated calcium entry (SOCE) that is coupled to the skeletal muscle ryanodine receptor, with 20 &microM azumolene

A muscle relaxant that inhibits the release of calcium from skeletal muscle sarcoplasmic reticulum inhibits a component of store-operated calcium entry (SOCE) that is coupled to the skeletal muscle ryanodine receptor, with 20 &microM azumolene

Beta-amyloid peptide (beta-APP) is a 40-residue peptide implicated in the pathogenesis of Alzheimer&rsquos disease (AD) and aged Down&#39s Syndrome, which is promoted by the acquisition of an additional copy of chromosome 21. The peptide is a

Beta-amyloid peptide (beta-APP) is a 40-residue peptide implicated in the pathogenesis of Alzheimer&rsquos disease (AD) and aged Down&#39s Syndrome, which is promoted by the acquisition of an additional copy of chromosome 21. The peptide is a

This peptide is well suited to the quantitative determination of A 42 peptide. Alzheimer&rsquos disease (AD) is characterized by the presence of extracellular plaques and intracellular neurofibrillary tangles (NFTs) in the brain.